Mohammad Ranaee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad Ranaee has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Barary
Student Research Committee, Department of Pharmacology School of Medicine, Shahid Beheshti University of Medical Sciences Tehran Iran
3 shared publications - Soheil Ebrahimpour
Infectious Diseases and Tropical Medicine Research Center Health Research Institute, Babol University of Medical Sciences Babol Iran
3 shared publications Alireza Firouzjahi
The Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran
2 shared publications- Fereshteh Mohammadizadeh
Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran
2 shared publications - Mahdieh Rajabi-Moghaddam
Department of Clinical Pathology, Birjand University of Medical Sciences, Birjand, South Khorasan Province, Iran, bums.ac.ir
2 shared publications - Abandansari
Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran
1 shared publication
Latest Publications
- 8 January 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 62
Vanillic Acid-Loaded Niosomes for Diabetic Wound Healing: Formulation, Optimization by Box–Behnken Design, and In Vivo Evaluation
In this study, a niosomal formulation of vanillic acid was successfully developed to enhance its poor aqueous solubility and antioxidant therapeutic potent
- 8 January 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 62
Vanillic Acid-Loaded Niosomes for Diabetic Wound Healing: Formulation, Optimization by Box–Behnken Design, and In Vivo Evaluation
In this study, a niosomal formulation of vanillic acid was successfully developed to enhance its poor aqueous solubility and antioxidant therapeutic potent
- 28 November 2025
- Published by Wiley in International Journal of Cancer
- Vol. 158 (5) , 1420-1421
Comments on “Plant‐based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort study”
- 28 November 2025
- Published by Wiley in International Journal of Cancer
- Vol. 158 (5) , 1420-1421
Comments on “Plant‐based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort study”
- 18 September 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (5) , 1-15
Repurposing disulfiram: targeting Zeb1 to attenuate paraquat-induced pulmonary fibrosis in rats
Pulmonary fibrosis is a fatal condition marked by excessive extracellular matrix deposition and myofibroblast activation, with paraquat (PQ) being a potent
- 18 September 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (5) , 1-15
Repurposing disulfiram: targeting Zeb1 to attenuate paraquat-induced pulmonary fibrosis in rats
Pulmonary fibrosis is a fatal condition marked by excessive extracellular matrix deposition and myofibroblast activation, with paraquat (PQ) being a potent
- Open Access
- 23 June 2025
- Vol. 16 (3) , 562-569
Prognosis of multiple myeloma patients based on histopathological evaluation of bone marrow
Multiple myeloma is still one of deadliest malignancies known. Although many attempts to prognosticate the disease have been done like the International Staging System (ISS), most of the proposed prognostic tools are based merely on laboratory tests and hence prone to analytical errors in large and high-volume centers. This study aims to evaluate the prognostic effectiveness of histopathologic components of bone marrow and compare it to the results of laboratory-based prognostic tools. This cross-sectional study, bone marrow specimens of 93 multiple myeloma patients underwent aspiration and biopsy evaluated. The primary outcome was overall survival (OS) based on plasma cell percentage. The secondary outcomes were also OS based on angiogenesis using IHC marker CD34, nuclear atypia level, BM involvement pattern and the presence of fibrosis in bone marrow specimens. All biopsy specimens assessed using light microscopy on Hematoxylin and Eosin and IHC staining. Giemsa staining assessed for aspirate specimens. Of 93 patients, 63.4% were dead. Median survival was 34.0 months (95% CI [24.6; 43.3]) and the average age at diagnosis was 65 years (highest 84 and lowest 40). Patients with bone marrow plasma cell count of over 70%, had a hazard ratio (HR) of death of 4.7 times more than those with plasma cell count between 10-25%. Similarly, diffuse infiltration pattern (HR 4.67) and blastic morphology (HR 4.17) associated with a significant worse prognosis (p=0.03). Comparing to laboratory-based ISS, wider HR of death spectrum in this study proposes a potential more precise, robust and easy-to-use prognostication tool.
- 23 June 2025
- Vol. 16 (3) , 562-569
Open AccessPrognosis of multiple myeloma patients based on histopathological evaluation of bone marrow
Multiple myeloma is still one of deadliest malignancies known. Although many attempts to prognosticate the disease have been done like the International Staging System (ISS), most of the proposed prognostic tools are based merely on laboratory tests and hence prone to analytical errors in large and high-volume centers. This study aims to evaluate the prognostic effectiveness of histopathologic components of bone marrow and compare it to the results of laboratory-based prognostic tools. This cross-sectional study, bone marrow specimens of 93 multiple myeloma patients underwent aspiration and biopsy evaluated. The primary outcome was overall survival (OS) based on plasma cell percentage. The secondary outcomes were also OS based on angiogenesis using IHC marker CD34, nuclear atypia level, BM involvement pattern and the presence of fibrosis in bone marrow specimens. All biopsy specimens assessed using light microscopy on Hematoxylin and Eosin and IHC staining. Giemsa staining assessed for aspirate specimens. Of 93 patients, 63.4% were dead. Median survival was 34.0 months (95% CI [24.6; 43.3]) and the average age at diagnosis was 65 years (highest 84 and lowest 40). Patients with bone marrow plasma cell count of over 70%, had a hazard ratio (HR) of death of 4.7 times more than those with plasma cell count between 10-25%. Similarly, diffuse infiltration pattern (HR 4.67) and blastic morphology (HR 4.17) associated with a significant worse prognosis (p=0.03). Comparing to laboratory-based ISS, wider HR of death spectrum in this study proposes a potential more precise, robust and easy-to-use prognostication tool.
- Open Access
- 15 May 2025
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 16 (8) , 1566-1567
Commentary on “Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus”
- 15 May 2025
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 16 (8) , 1566-1567
Open AccessCommentary on “Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus”
- Open Access
- 21 April 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (4) , e70051
Commentary on “Association of Plasma Homocysteine With Peripheral Arterial Disease in Hypertensive Adults: A Cross‐Sectional Study”
- 21 April 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (4) , e70051
Open AccessCommentary on “Association of Plasma Homocysteine With Peripheral Arterial Disease in Hypertensive Adults: A Cross‐Sectional Study”
- Open Access
- 1 July 2024
- Published by InkVista Publishing House
- Vol. 18 (4) , 27-31
Isolation of Pasteurella multocida and pan-drug-resistant bacteria causing nosocomial infection in a patient with multiple sclerosis: A Case Report and Literature Review
Pasteurella species are one of the most common pathogenic bacteria in domestic animals, and they are seen more in people with weak immune systems. This research aims to investigate a case of a patient with multiple sclerosis from whose sputum Pasteurella multocida (P. multocida) was isolated. The patient was a 28-year-old man with ...
- 1 July 2024
- Published by InkVista Publishing House
- Vol. 18 (4) , 27-31
Open AccessIsolation of Pasteurella multocida and pan-drug-resistant bacteria causing nosocomial infection in a patient with multiple sclerosis: A Case Report and Literature Review
Pasteurella species are one of the most common pathogenic bacteria in domestic animals, and they are seen more in people with weak immune systems. This research aims to investigate a case of a patient with multiple sclerosis from whose sputum Pasteurella multocida (P. multocida) was isolated. The patient was a 28-year-old man with ...
- Open Access
- 25 November 2023
- Published by Springer Nature in Research Square
Relationship Between Ki-67 And Breast Cancer A historical cohort study
Purpose According to past studies and the importance of Ki-67 in breast cancer, a clear cut-off point for prognosis and prediction of recurrence has not yet been determined; Therefore, the purpose of this study is to investigate the level of Ki-67 in breast cancer patients and its relationship with other laboratory markers and clinical findings, and finally its relationship with patient survival. Methods Patient information was extracted from their medical records. patients in stages Ⅱ and Ⅲ who underwent a mastectomy, chemotherapy, radiation, and hormone therapy were included in the study, and patients with incomplete information were excluded. According to the Ki-67 level, patients were divided into three groups and followed up for 36 months. Results According to the inclusion and exclusion criteria, 500 patients were included in the study. Ki-67 level had a significant relationship with disease stage (p = 0.037), tumor size (p = 0.006), estrogen (p < 0.001), and progesterone (p < 0.001) receptors, HER2 (p < 0.001) and molecular subgroups (p < 0.001), as well as with disease-free interval (DFI) (p < 0.001), but it had no significant relationship with patients' age and lymph nodes. In examining the relationship between Ki-67 level and disease-free interval in each molecular subgroup, there was a significant relationship only in luminal A (p = 0.003) and luminal B (p = 0.004) subgroups, and it was not significant in HER2-enrich and triple-negative subgroups. Conclusion Ki-67 can be useful in predicting recurrence, especially in patients in luminal A and luminal B molecular subgroups.
- 25 November 2023
- Published by Springer Nature in Research Square
Open AccessRelationship Between Ki-67 And Breast Cancer A historical cohort study
Purpose According to past studies and the importance of Ki-67 in breast cancer, a clear cut-off point for prognosis and prediction of recurrence has not yet been determined; Therefore, the purpose of this study is to investigate the level of Ki-67 in breast cancer patients and its relationship with other laboratory markers and clinical findings, and finally its relationship with patient survival. Methods Patient information was extracted from their medical records. patients in stages Ⅱ and Ⅲ who underwent a mastectomy, chemotherapy, radiation, and hormone therapy were included in the study, and patients with incomplete information were excluded. According to the Ki-67 level, patients were divided into three groups and followed up for 36 months. Results According to the inclusion and exclusion criteria, 500 patients were included in the study. Ki-67 level had a significant relationship with disease stage (p = 0.037), tumor size (p = 0.006), estrogen (p < 0.001), and progesterone (p < 0.001) receptors, HER2 (p < 0.001) and molecular subgroups (p < 0.001), as well as with disease-free interval (DFI) (p < 0.001), but it had no significant relationship with patients' age and lymph nodes. In examining the relationship between Ki-67 level and disease-free interval in each molecular subgroup, there was a significant relationship only in luminal A (p = 0.003) and luminal B (p = 0.004) subgroups, and it was not significant in HER2-enrich and triple-negative subgroups. Conclusion Ki-67 can be useful in predicting recurrence, especially in patients in luminal A and luminal B molecular subgroups.
- 1 August 2023
- Published by Taylor & Francis in Future Virology
- Vol. 18 (11) , 699-704
Evaluation of Human Papillomavirus Type 197 Genome in non-melanoma Skin Cancer and Adjacent non-tumoral Skin Margins
Aim: We aimed to investigate the presence of human papillomavirus type 197 (HPV197) in patients with cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Materials & methods: 58 ... Plain language summary The skin is one of the most common sites of cancer. Several risk factors have been studied for skin cancer, including viral infections. The human papillomavirus (HPV) is one ...
- 1 August 2023
- Published by Taylor & Francis in Future Virology
- Vol. 18 (11) , 699-704
Evaluation of Human Papillomavirus Type 197 Genome in non-melanoma Skin Cancer and Adjacent non-tumoral Skin Margins
Aim: We aimed to investigate the presence of human papillomavirus type 197 (HPV197) in patients with cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Materials & methods: 58 ... Plain language summary The skin is one of the most common sites of cancer. Several risk factors have been studied for skin cancer, including viral infections. The human papillomavirus (HPV) is one ...